This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2023 Feb 1;41(4):732-735.

doi: 10.1200/JCO.22.02217. Epub 2022 Nov 29.

Antibody-Drug Conjugates in Breast Cancer: Searching for Magic Bullets

Cesar A Santa-Maria¹, Antonio C Wolff¹

Affiliations

PMID: 36446052
DOI: 10.1200/JCO.22.02217

Editorial

Antibody-Drug Conjugates in Breast Cancer: Searching for Magic Bullets

Cesar A Santa-Maria et al. J Clin Oncol. 2023.

. 2023 Feb 1;41(4):732-735.

doi: 10.1200/JCO.22.02217. Epub 2022 Nov 29.

Authors

Cesar A Santa-Maria¹, Antonio C Wolff¹

Affiliation

¹ The Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD.

PMID: 36446052
DOI: 10.1200/JCO.22.02217

No abstract available

PubMed Disclaimer

Comment on

Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.
Rugo HS, Bardia A, Marmé F, Cortes J, Schmid P, Loirat D, Trédan O, Ciruelos E, Dalenc F, Pardo PG, Jhaveri KL, Delaney R, Fu O, Lin L, Verret W, Tolaney SM. Rugo HS, et al. J Clin Oncol. 2022 Oct 10;40(29):3365-3376. doi: 10.1200/JCO.22.01002. Epub 2022 Aug 26. J Clin Oncol. 2022. PMID: 36027558 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information